{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:47:18Z","timestamp":1784342838345,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tissue Eng Regen Med"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s13770-024-00664-y","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T14:57:08Z","timestamp":1722956228000},"page":"1079-1092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Zinc-Alpha-2-Glycoprotein Peptide Downregulates Type I and III Collagen Expression via Suppression of TGF-\u03b2 and p-Smad 2\/3 Pathway in Keloid Fibroblasts and Rat Incisional Model"],"prefix":"10.1007","volume":"21","author":[{"given":"Shin Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Min","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Jai","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"664_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/exd.14121","volume":"30","author":"GC Limandjaja","year":"2021","unstructured":"Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S. Hypertrophic scars and keloids: overview of the evidence and practical guide for differentiating between these abnormal scars. Exp Dermatol. 2021;30:146\u201361.","journal-title":"Exp Dermatol"},{"key":"664_CR2","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1365-2133.2009.09511.x","volume":"162","author":"S He","year":"2010","unstructured":"He S, Liu X, Yang Y, Huang W, Xu S, Yang S, Zhang X, Roberts MS. Mechanisms of transforming growth factor beta(1)\/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts. Br J Dermatol. 2010;162:538\u201346.","journal-title":"Br J Dermatol"},{"key":"664_CR3","doi-asserted-by":"publisher","first-page":"110287","DOI":"10.1016\/j.biopha.2020.110287","volume":"129","author":"T Zhang","year":"2020","unstructured":"Zhang T, Wang XF, Wang ZC, Lou D, Fang QQ, Hu YY, Zhao WY, Zhang LY, Wu LH, Tan WQ. Current potential therapeutic strategies targeting the TGF-beta\/Smad signaling pathway to attenuate keloid and hypertrophic scar formation. Biomed Pharmacother. 2020;129:110287.","journal-title":"Biomed Pharmacother"},{"key":"664_CR4","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1111\/jocd.14310","volume":"20","author":"ML Elsaie","year":"2021","unstructured":"Elsaie ML. Update on management of keloid and hypertrophic scars: a systemic review. J Cosmet Dermatol. 2021;20:2729\u201338.","journal-title":"J Cosmet Dermatol"},{"key":"664_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2147\/CCID.S133672","volume":"11","author":"M Morelli Coppola","year":"2018","unstructured":"Morelli Coppola M, Salzillo R, Segreto F, Persichetti P. Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives. Clin Cosmet Investig Dermatol. 2018;11:387\u201396.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"664_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40264-015-0287-7","volume":"38","author":"L Barnes","year":"2015","unstructured":"Barnes L, Kaya G, Rollason V. Topical corticosteroid-induced skin atrophy: a comprehensive review. Drug Saf. 2015;38:493\u2013509.","journal-title":"Drug Saf"},{"key":"664_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0190-9622(95)90035-7","volume":"33","author":"B Berman","year":"1995","unstructured":"Berman B, Bieley HC. Keloids. J Am Acad Dermatol. 1995;33:117\u201323.","journal-title":"J Am Acad Dermatol"},{"key":"664_CR8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0021-9258(18)64243-7","volume":"236","author":"W B\u00fcrgi","year":"1961","unstructured":"B\u00fcrgi W, Schmid K. Preparation and properties of Zn-\u03b12-glycoprotein of normal human plasma. J Biol Chem. 1961;236:1066\u201374.","journal-title":"J Biol Chem"},{"key":"664_CR9","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1177\/39.9.1918940","volume":"39","author":"T Tada","year":"1991","unstructured":"Tada T, Ohkubo I, Niwa M, Sasaki M, Tateyama H, Eimoto T. Immunohistochemical localization of Zn-A2-glycoprotein in normal human tissues. J Histochem Cytochem. 1991;39:1221\u20136.","journal-title":"J Histochem Cytochem"},{"key":"664_CR10","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1038\/onc.2010.258","volume":"29","author":"B Kong","year":"2010","unstructured":"Kong B, Michalski CW, Hong X, Valkovskaya N, Rieder S, Abiatari I, Streit S, Erkan M, Esposito I, Friess H, Kleeff J. AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-beta-mediated ERK signaling. Oncogene. 2010;29:5146\u201358.","journal-title":"Oncogene"},{"key":"664_CR11","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3390\/ijms20112767","volume":"20","author":"Y Hao","year":"2019","unstructured":"Hao Y, Baker D, Ten Dijke P. TGF-beta-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci. 2019;20:2767.","journal-title":"Int J Mol Sci"},{"key":"664_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1096\/fasebj.14.3.565","volume":"14","author":"SH Chen","year":"2000","unstructured":"Chen SH, Arany I, Apisarnthanarax N, Rajaraman S, Tyring SK, Horikoshi T, Brysk H, Brysk MM. Response of keratinocytes from normal and psoriatic epidermis to interferon-gamma differs in the expression of zinc-alpha(2)-glycoprotein and cathepsin D. FASEB J. 2000;14:565\u201371.","journal-title":"FASEB J"},{"key":"664_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.febslet.2004.11.042","volume":"579","author":"Y Bao","year":"2005","unstructured":"Bao Y, Bing C, Hunter L, Jenkins JR, Wabitsch M, Trayhurn P. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett. 2005;579:41\u20137.","journal-title":"FEBS Lett"},{"key":"664_CR14","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.jid.2019.01.023","volume":"139","author":"JY Noh","year":"2019","unstructured":"Noh JY, Shin JU, Kim JH, Kim SH, Kim BM, Kim YH, Park S, Kim TG, Shin KO, Park K, Lee KH. ZAG regulates the skin barrier and immunity in atopic dermatitis. J Invest Dermatol. 2019;139:1648\u201357.","journal-title":"J Invest Dermatol"},{"key":"664_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1089\/ten.tec.2017.0464","volume":"24","author":"GC Limandjaja","year":"2018","unstructured":"Limandjaja GC, van den Broek LJ, Breetveld M, Waaijman T, Monstrey S, de Boer EM, Scheper RJ, Niessen FB, Gibbs S. Characterization of in vitro reconstructed human normotrophic, hypertrophic, and keloid scar models. Tissue Eng Part C Methods. 2018;24:242\u201353.","journal-title":"Tissue Eng Part C Methods"},{"key":"664_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fcell.2020.00360","volume":"8","author":"GC Limandjaja","year":"2020","unstructured":"Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S. The keloid disorder: heterogeneity, histopathology, mechanisms and models. Front Cell Dev Biol. 2020;8:360.","journal-title":"Front Cell Dev Biol"},{"key":"664_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3892\/br.2013.169","volume":"1","author":"X Dong","year":"2013","unstructured":"Dong X, Mao S, Wen H. Upregulation of proinflammatory genes in skin lesions may be the cause of keloid formation. Biomed Rep. 2013;1:833\u20136.","journal-title":"Biomed Rep"},{"key":"664_CR18","first-page":"23","volume":"2022","author":"BK Jung","year":"2022","unstructured":"Jung BK, Roh TS, Roh H, Lee JH, Yun CO, Lee WJ. Effect of mortalin on scar formation in human dermal fibroblasts and a rat incisional scar model. Int J Mol Sci. 2022;2022:23.","journal-title":"Int J Mol Sci"},{"key":"664_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.matbio.2016.01.013","volume":"51","author":"JP Andrews","year":"2016","unstructured":"Andrews JP, Marttala J, Macarak E, Rosenbloom J, Uitto J. Keloids: the paradigm of skin fibrosis-pathomechanisms and treatment. Matrix Biol. 2016;51:37\u201346.","journal-title":"Matrix Biol"},{"key":"664_CR20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/1523-1747.ep12398532","volume":"103","author":"A Ghahary","year":"1994","unstructured":"Ghahary A, Shen YJ, Scott PG, Tredget EE. Expression of mRNA for transforming growth factor-beta 1 is reduced in hypertrophic scar and normal dermal fibroblasts following serial passage in vitro. J Invest Dermatol. 1994;103:684\u20136.","journal-title":"J Invest Dermatol"},{"key":"664_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/08977194.2011.595714","volume":"29","author":"A Iernacka","year":"2011","unstructured":"Iernacka A, Dobaczewski M, Frangogiannis NG. TGF-\u03b2 signaling in fibrosis. Growth Factors. 2011;29:196\u2013202.","journal-title":"Growth Factors"},{"key":"664_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685\u2013700.","journal-title":"Cell"},{"key":"664_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00775-012-0886-z","volume":"17","author":"GF Fasciglione","year":"2012","unstructured":"Fasciglione GF, Gioia M, Tsukada H, Liang J, Iundusi R, Tarantino U, Coletta M, Pourmotabbed T, Marini S. The collagenolytic action of MMP-1 is regulated by the interaction between the catalytic domain and the hinge region. J Biol Inorg Chem. 2012;17:663\u201372.","journal-title":"J Biol Inorg Chem"},{"key":"664_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jdermsci.2003.12.006","volume":"35","author":"M Schiller","year":"2004","unstructured":"Schiller M, Javelaud D, Mauviel A. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci. 2004;35:83\u201392.","journal-title":"J Dermatol Sci"},{"key":"664_CR25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s10875-005-7827-3","volume":"25","author":"RK Bhogal","year":"2005","unstructured":"Bhogal RK, Stoica CM, McGaha TL, Bona CA. Molecular aspects of regulation of collagen gene expression in fibrosis. J Clin Immunol. 2005;25:592\u2013603.","journal-title":"J Clin Immunol"},{"key":"664_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/ijms17040455","volume":"17","author":"T Latronico","year":"2016","unstructured":"Latronico T, Mascia C, Pati I, Zuccala P, Mengoni F, Marocco R, Tieghi T, Belvisi V, Lichtner M, Vullo V, Mastroianni CM, Liuzzi GM. Liver fibrosis in HCV monoinfected and HIV\/HCV coinfected patients: dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors. Int J Mol Sci. 2016;17:455.","journal-title":"Int J Mol Sci"},{"key":"664_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2133.2005.06698.x","volume":"153","author":"M Fujiwara","year":"2005","unstructured":"Fujiwara M, Muragaki Y, Ooshima A. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol. 2005;153:295\u2013300.","journal-title":"Br J Dermatol"},{"key":"664_CR28","first-page":"2919","volume":"30","author":"V Dubois","year":"2010","unstructured":"Dubois V, Delort L, Mishellany F, Jarde T, Billard H, Lequeux C, et al. Zinc-\u03b12-glycoprotein: a new biomarker of breast cancer? Anticancer Res. 2010;30:2919\u201325.","journal-title":"Anticancer Res"},{"key":"664_CR29","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1158\/1541-7786.MCR-07-2195","volume":"6","author":"MI Hassan","year":"2008","unstructured":"Hassan MI, Waheed A, Yadav S, Singh TP, Ahmad F. Zinc alpha 2-glycoprotein: a multidisciplinary protein. Mol Cancer Res. 2008;6:892\u2013906.","journal-title":"Mol Cancer Res"},{"key":"664_CR30","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/carcin\/bgt056","volume":"34","author":"D Ji","year":"2013","unstructured":"Ji D, Li M, Zhan T, Yao Y, Shen J, Tian H, Zhang Z, Gu J. Prognostic role of serum AZGP1, PEDF and PRDX2 in colorectal cancer patients. Carcinogenesis. 2013;34:1265\u201372.","journal-title":"Carcinogenesis"},{"key":"664_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1074\/jbc.M804777200","volume":"284","author":"K Horiguchi","year":"2009","unstructured":"Horiguchi K, Shirakihara T, Nakano A, Imamura T, Miyazono K, Saitoh M. Role of ras signaling in the induction of snail by transforming growth factor-beta. J Biol Chem. 2009;284:245\u201353.","journal-title":"J Biol Chem"},{"key":"664_CR32","doi-asserted-by":"publisher","first-page":"e0129644","DOI":"10.1371\/journal.pone.0129644","volume":"10","author":"V Ceperuelo-Mallafre","year":"2015","unstructured":"Ceperuelo-Mallafre V, Ejarque M, Duran X, Pachon G, Vazquez-Carballo A, Roche K, Nunez-Roa C, Garrido-Sanchez L, Tinahones FJ, Vendrell J, Fernandez-Veledo S. Zinc-alpha2-glycoprotein modulates AKT-dependent insulin signaling in human adipocytes by activation of the PP2A phosphatase. PLoS One. 2015;10:e0129644.","journal-title":"PLoS One"},{"key":"664_CR33","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/ijo.2010.105","volume":"34","author":"C Bing","year":"2010","unstructured":"Bing C, Mracek T, Gao D, Trayhurn P. Zinc-alpha2-glycoprotein: an adipokine modulator of body fat mass? Int J Obes. 2010;34:1559\u201365.","journal-title":"Int J Obes"},{"key":"664_CR34","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/onc.2010.565","volume":"30","author":"J Malapeira","year":"2011","unstructured":"Malapeira J, Esselens C, Bech-Serra JJ, Canals F, Arribas J. ADAM17 (TACE) regulates TGFbeta signaling through the cleavage of vasorin. Oncogene. 2011;30:1912\u201322.","journal-title":"Oncogene"}],"container-title":["Tissue Engineering and Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-024-00664-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13770-024-00664-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-024-00664-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T12:05:11Z","timestamp":1726920311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13770-024-00664-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1007\/s13770-024-00664-y","relation":{},"ISSN":["1738-2696","2212-5469"],"issn-type":[{"value":"1738-2696","type":"print"},{"value":"2212-5469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"3 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Yonsei University College of Medicine (IRB No. 4\u20132015-0228). The animal study protocol was approved by the Institutional Animal Care and Use Committee of Yonsei University (#2018\u20132019, approved by July 16, 2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}